123 related articles for article (PubMed ID: 11848738)
1. Summaries for patients. Lung function and death from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes.
Ann Intern Med; 2002 Feb; 136(4):I35. PubMed ID: 11848738
[No Abstract] [Full Text] [Related]
2. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population.
Dahl M; Tybjaerg-Hansen A; Lange P; Vestbo J; Nordestgaard BG
Ann Intern Med; 2002 Feb; 136(4):270-9. PubMed ID: 11848724
[TBL] [Abstract][Full Text] [Related]
3. Alpha one antitrypsin deficiency: from gene to treatment.
Wood AM; Stockley RA
Respiration; 2007; 74(5):481-92. PubMed ID: 17671403
[TBL] [Abstract][Full Text] [Related]
4. [The variability of clinical presentation of chronic obstructive pulmonary disease in patients with hereditary alpha-1 antitrypsin deficiency].
Kuca P; Kamiński D; Campbell E; Kołakowski J; Goljan-Geremek A; Puścińska E; Bieleń P; Nowiński A; Wojda E; Hawryłkiewicz I; Sliwiński P; Górecka D
Pneumonol Alergol Pol; 2004; 72(9-10):420-3. PubMed ID: 16021998
[TBL] [Abstract][Full Text] [Related]
5. Heritability of lung function in severe alpha-1 antitrypsin deficiency.
DeMeo DL; Campbell EJ; Brantly ML; Barker AF; Eden E; McElvaney NG; Rennard SI; Stocks JM; Stoller JK; Strange C; Turino G; Sandhaus RA; Silverman EK
Hum Hered; 2009; 67(1):38-45. PubMed ID: 18931508
[TBL] [Abstract][Full Text] [Related]
6. Familial risks for chronic obstructive pulmonary disease among siblings based on hospitalisations in Sweden.
Hemminki K; Li X; Sundquist K; Sundquist J
J Epidemiol Community Health; 2008 May; 62(5):398-401. PubMed ID: 18413451
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of alpha-1 antitrypsin level for inherited deficiency detection in COPD patients.
Serapinas D; Sakalauskas R
Pneumologia; 2012; 61(1):34-6. PubMed ID: 22545487
[TBL] [Abstract][Full Text] [Related]
8. Alpha-antitrypsin genotypes in Korean patients with chronic obstructive pulmonary disease.
Kim CH; Yim JJ; Yoo CG; Lee CT; Kim YW; Han SK; Shim YS
Respirology; 2005 Mar; 10(2):223-8. PubMed ID: 15823189
[TBL] [Abstract][Full Text] [Related]
9. COPD: new lessons from alpha1-antitrypsin deficiency?
Wanner A
Chest; 2009 May; 135(5):1342-1344. PubMed ID: 19420201
[No Abstract] [Full Text] [Related]
10. The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency.
Greene CM; Hassan T; Molloy K; McElvaney NG
Expert Rev Respir Med; 2011 Jun; 5(3):395-411. PubMed ID: 21702661
[TBL] [Abstract][Full Text] [Related]
11. [Genetics in chronic obstructive pulmonary disease].
Sørheim IC; Gulsvik A; Bakke PS; Brøgger JC; Grydeland TB; Silverman EK
Tidsskr Nor Laegeforen; 2009 Oct; 129(20):2104-7. PubMed ID: 19855448
[No Abstract] [Full Text] [Related]
12. Screening for alpha1-antitrypsin deficiency in Lithuanian patients with COPD.
Sitkauskiene B; Serapinas D; Blanco I; Fernández-Bustillo E; Janciauskiene S; Sakalauskas R
Respir Med; 2008 Nov; 102(11):1654-8. PubMed ID: 18722101
[TBL] [Abstract][Full Text] [Related]
13. COPD in individuals with the PiMZ alpha-1 antitrypsin genotype.
Al Ashry HS; Strange C
Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29070580
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic differences in alpha 1 antitrypsin-deficient sibling pairs may relate to genetic variation.
Wood AM; Needham M; Simmonds MJ; Newby PR; Gough SC; Stockley RA
COPD; 2008 Dec; 5(6):353-9. PubMed ID: 19353349
[TBL] [Abstract][Full Text] [Related]
15. Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy.
Cox DW; Hoeppner VH; Levison H
Am Rev Respir Dis; 1976 May; 113(5):601-6. PubMed ID: 1083700
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.
Hollander C; Westin U; Wallmark A; Piitulainen E; Sveger T; Janciauskiene SM
BMC Pulm Med; 2007 Jan; 7():1. PubMed ID: 17261175
[TBL] [Abstract][Full Text] [Related]
17. Risk of Lung Disease in PI MZ Heterozygotes. Current Status and Future Research Directions.
Silverman EK
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4(Suppl 4):S341-5. PubMed ID: 27564671
[TBL] [Abstract][Full Text] [Related]
18. Chronic obstructive pulmonary disease: diagnostic considerations.
Dewar M; Curry RW
Am Fam Physician; 2006 Feb; 73(4):669-76. PubMed ID: 16506711
[TBL] [Abstract][Full Text] [Related]
19. Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis.
Hersh CP; Dahl M; Ly NP; Berkey CS; Nordestgaard BG; Silverman EK
Thorax; 2004 Oct; 59(10):843-9. PubMed ID: 15454649
[TBL] [Abstract][Full Text] [Related]
20. [Heterozygosity for alpha1-antitrypsin deficiency as a cofactor in the development of chronic liver disease].
Kok KF; Wahab PJ; de Vries RA
Ned Tijdschr Geneeskd; 2005 Sep; 149(37):2057-61. PubMed ID: 16184948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
